Jounce Therapeutics, Inc. Gains 55.58%

Tue, Sep 01, 2020 at 05:30 PM
Jounce Therapeutics, Inc. Gains 55.58%

Jounce Therapeutics, Inc. (JNCE:NASDAQ) shot up at $7.53, a gain of 55.6%. The stock appeared on our News Catalysts scanner on Tue 01 Sep 20 at 08:40 AM in the 'AGREEMENT' category. From Mon 17 Aug 20, the stock recorded 50.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Jounce Therapeutics, Inc. (JNCE:NASDAQ)

Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.